Gilead Sciences Inc annual shares outstanding for fiscal TTM was 1,254 million shares, a decrease of 0.1% from 1,255 million shares in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Shares Outstanding (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (M) | 1,254M | 1,255M | 1,255M | 1,258M | 1,262M | 1,262M | 1,263M | 1,277M | 1,308M | 1,319M | 1,358M | 1,521M | 1,647M | 1,695M | 1,583M | 1,580M | 1,747M | 1,868M | 1,918M | 1,929M | 1,836M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Shares Outstanding (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (M) | 1,254M | 1,253M | 1,254M | 1,255M | 1,259M | 1,259M | 1,254M | 1,251M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More GILD metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow
All GILD financial statements → Interactive GILD charts →
About TickerBase · Data methodology & sources